United States Quinn v. Omnicare Inc’s Empirical Analysis
382 F.3d 432 · 2004
Citation profile
9 federal appellate · 10 district ·
How this case has been cited
Cited by 56 later decisions — most recently March 2020 · most notably United States ex rel. Grubbs v. Kanneganti (2009), United States ex rel. Wilkins v. United Health Group, Inc. (2011)
9 federal appellate · 10 district ·
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Relies on Harrison v. Westinghouse Savannah River Co. · United States Clausen v. Laboratory Corporation of America Inc · Hollinger v. Wagner Mining Equipment Co. · Mikes v. Straus · Continental Insurance v. Bodie
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 56 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“[T]he court held that a False Claims Act plaintiff cannot ‘merely ... describe a private scheme in detail but then ... allege simply and without any stated reason for his belief that claims requesting illegal payments must have submitted, were likely submitted or should have been submitted to the Government.’”
2 later decisions quote this exact passage · from the majority“[E]ven assuming that [defendant] is submitting successive claims for the same medications, there can be no FCA liability because New Jersey regulations entitle [defendant] to recycle and redispense returned medications. Section 13:39-9.15(a)(2) of the New Jersey Administrative Code, entitled “Disposal of unused medications,” allows unused unit dose packaged medication, that “has been stored in a medication room or secure area in the institution ... [with the] seal and control number ... intact” to be “recycled and redispensed.” The regulation does not, however, require pharmacies to credit Medicaid for the “recycled and redispensed” medications. Because [defendant] can legally recycle returned medications, the initial sale and the subsequent sale of a returned medication are properly viewed as separate transactions. As the District Court held, these transactions are “not duplicative in any sense that would make them inconsistent with the full-payment representation on the MC-6.” Under this separate transaction theory, [defendant] does not make a false representation on the second claim form even though it does not state that Medicaid has already paid, at least in part, for a redispensed medication. In so concluding, we recognize that the second claim would be submitted to Medicaid for payment for the same medication. When [defendant] submits the second claim, it knows that the medication, which is the subject of that claim, was already dispensed once and returned— However, be”
1 later decision quote this exact passage · from the majority“The FCA allows a private citizen, called a relator, to bring an action in the name of the United States, and the government may intervene if it so chooses.... The FCA permits the relator to bring the action in the absence of the government's intervention.” U.S. ex rel. Quinn v. Omnicare Inc., 382 F.3d 432 , 436 n. 7 (3d Cir.2004). As in Quinn, the government declined to intervene in this case. 3 .The FCA reaches”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.